CHAIRMAN'S SPEECH

With the strong support of governments and various sectors of society at all levels,our team has strived for over a decade addressing to the pain points and challenges in the fields of the chemical intermediate through independent research,we have developped innovated safe, environmentally friendly,and economical synthetic processes to replace traditional methods,and carved out a green chemical production path characterized by Benli's unique approach. 

In the future, based on the chemical intermediate industry, relying on the Three Major Technology Platforms,our company will implement the concept of "prioritizing clean production with supplementary end-of-pipe treatment", transform the traditional process with the core technology independently researched and developed, continue to take the responsibility of providing cost-effective and good intermediates for the industry, provide customers with high-quality products and services, enhance profitability and control operational risks, and gradually develop into an internationally competitive supplier of chemical intermediates and APIs.

“A gentlemen should do the foundation. Once the foundation established, the natural law will come into being. A towering tree certainly has its corresponding root. ”To build an enterprise centuries old, its root and foundation must be consolidated first.

Our company will always adhere to the core corporate values of "honest, frugality, integrity, perfection, innovation, and sharing." Our mission is to contribute green chemical concepts and products to society and create a harmonious and beautiful future for humanity. We are dedicated to laying a solid foundation for business development, diligently fostering an enterprising spirit, striving tirelessly for the growth of the enterprise, achievement of employees, service to customers, and giving back to society.

COMPANY PROFILE

ZHEJIANG BENLI TECHNOLOGY CO., LTD. is a national high-tech enterprise, focusing on the field of chemical intermediates, devoting itself to the R&D, production and sales of pharmaceutical intermediates, pesticide intermediates and new material intermediates, always insisting on taking innovation as the drive, and aiming at the pain points and difficulties existing in the application field of chemical intermediates industry, developing safe, environmentally-friendly and economical synthetic processes to replace traditional processes. It’s a professional enterprise focusing on clean production of chemical intermediate in China. The Company has strong competitive advantages in R&D and technical service capability, stable supply capability and brand influence. It has outstanding R&D capability and strong independent innovation capability, and owns many patented and non-patented technologies, including 24 invention patents and More than 10 utility model patents, and undertakes many major scientific research projects. In 2016, it was awarded honors such as the “First Prize of Science and Technology Progress in Zhejiang Province”, the “First Prize of Science and Technology Progress in China Petroleum and Chemical Industry Federation” and the “First Prize of National Innovation Cooperation Achievements in Industry-University-Research”.

The Company focuses on the research of the green process route of quinolone APIs and key intermediates, and has created technical platforms such as carbon monoxide carbonylation reaction, carbon tetrachloride Friedel-Crafts reaction and green synthesis of quinolone APIs, realized the industrialization of key intermediates such as Products 801 and 1201, and unified some productions process of quinolone APIs on one large platform through the above key intermediates, which effectively solved the industrial problems such as large consumption of toxic and harmful raw materials, large amount of "Three Wastes" and high production cost, and created conditions for large-scale, cyclic, continuous and automatic production of quinolone APIs and key intermediates.

The Company's Products 801 and 1201 have been individually or jointly applied to more than ten quinolone APIs such as Ofloxacin, Levofloxacin, Ciprofloxacin, Enrofloxacin and Norfloxacin, etc. With the extension of process substitution, they will be applied to more quinolone APIs in the future. In addition to the application of pharmaceutical intermediates, 

CULTURE

HONORS